Cancer patients frequently report altered taste perception — a phenomenon long attributed to treatment side effects but whose biological origins remain poorly understood. New findings published in PNAS suggest that tumors themselves, independent of any therapy, can actively remodel sensory circuits governing taste, with implications for understanding cancer-associated anorexia and malnutrition.
Using Drosophila as a genetically tractable model, researchers identified a signaling cascade through which tumor tissue remotely amplifies bitter taste neuron sensitivity. Tumors were found to secrete the cytokine Unpaired 3 (Upd3), which initiates a relay: Upd3 triggers production of Spätzle 5 (Spz5), a neurotrophin-like ligand that then activates Toll-6 receptors expressed on peripheral bitter gustatory neurons. This three-molecule axis — Upd3/Spz5/Toll-6 — was sufficient to heighten avoidance of bitter tastants such as caffeine, effectively suppressing feeding behavior without direct tumor invasion of neural tissue. The finding establishes a humoral, endocrine-like route by which a tumor manipulates chemosensory circuits at a distance.
The relevance to human cancer biology hinges on conservation. The bitter taste transduction machinery is broadly conserved from insects to mammals, and mammalian homologs of Toll-6 (Toll-like receptors) and neurotrophins are expressed in taste receptor cells and associated neurons. If an analogous cytokine relay operates in humans, it could partially explain the food aversion and appetite suppression that precede diagnosis in many cancer patients — symptoms currently lacking mechanistic explanation. This is a genuinely novel mechanistic pathway, not merely descriptive. Key limitations are its animal-model basis and the significant evolutionary distance between Drosophila and humans. Whether Upd3 or a functional mammalian equivalent drives similar taste changes in rodent cancer models or clinical cohorts remains to be established. Still, the conceptual framing — tumors as active remodelers of peripheral sensory neurons via secreted signals — represents a meaningful shift in how cancer's systemic effects on appetite should be studied.